In this study, we found for the first time that low sensitivity to gefitinib in wild‐type EGFR NSCLC cell lines was attributable to a survival mechanism through clathrin‐mediated EGFR endocytosis. This evidence concerns the gene EGFR and non-small cell lung carcinoma.